Our goal is to provide a quick, efficient, and user-friendly method of determining whether a patient is eligible to take the BRCA test. We hope that this questionnaire can reach people worldwide, helping facilitate early detection and intervention.
1 in 8 women will be diagnosed with breast cancer in their lifetime. 10% of breast cancer cases are associated with BRCA genetic mutations. BRCA genes are tumor-suppressing genes that help repair DNA. The lifetime risk of an American woman developing breast cancer is about 13%. Women with mutations in these BRCA genes have a 50 to 85% risk of developing breast cancer. With earlier diagnoses and interventions in these patients, survival rates can be increased by over 20%.
Although the guidelines for BRCA genetic screening are well-established and these mutations can be detected with a simple blood test, a significant number of these mutations remain undetected. The current guidelines are complex, redundant, scattered across multiple sources, and require sophistication and expertise to comprehend. This makes it difficult for even primary care physicians to effectively understand and use this information, let alone patients. Our goal was to make the use and implementation of these guidelines much easier so people can benefit from this test worldwide. To achieve this, we consolidated these complex genetic screening guidelines from multiple sources and leveraged technology to create a simple, intuitive, and intelligent, web-based, user interface, powered by a sophisticated algorithm on the back-end